WuXi veteran Shuyuan Yao has been named chief executive officer of Allogene Overland Biopharm, a company formed by Allogene Therapeutics and Overland Pharmaceuticals in December to advance CAR-T cell therapies in China and other Asian markets.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,